These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 21546906)
1. Zac1 is a histone acetylation-regulated NF-κB suppressor that mediates histone deacetylase inhibitor-induced apoptosis. Shu G; Tang Y; Zhou Y; Wang C; Song JG Cell Death Differ; 2011 Dec; 18(12):1825-35. PubMed ID: 21546906 [TBL] [Abstract][Full Text] [Related]
2. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells. Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983 [TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. Hu J; Colburn NH Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876 [TBL] [Abstract][Full Text] [Related]
4. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Ashburner BP; Westerheide SD; Baldwin AS Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889 [TBL] [Abstract][Full Text] [Related]
5. HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity. Leus NG; van der Wouden PE; van den Bosch T; Hooghiemstra WTR; Ourailidou ME; Kistemaker LE; Bischoff R; Gosens R; Haisma HJ; Dekker FJ Biochem Pharmacol; 2016 May; 108():58-74. PubMed ID: 26993378 [TBL] [Abstract][Full Text] [Related]
6. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines. Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183 [TBL] [Abstract][Full Text] [Related]
7. Disruption of IkappaB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitors. Dai Y; Chen S; Wang L; Pei XY; Funk VL; Kramer LB; Dent P; Grant S J Biol Chem; 2011 Sep; 286(39):34036-50. PubMed ID: 21816815 [TBL] [Abstract][Full Text] [Related]
8. Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells. Batra S; Sahu RP; Kandala PK; Srivastava SK Mol Cancer Ther; 2010 Jun; 9(6):1596-608. PubMed ID: 20484017 [TBL] [Abstract][Full Text] [Related]
9. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes. Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940 [TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation. Law AY; Lai KP; Lui WC; Wan HT; Wong CK Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825 [TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101. Duan J; Friedman J; Nottingham L; Chen Z; Ara G; Van Waes C Mol Cancer Ther; 2007 Jan; 6(1):37-50. PubMed ID: 17237265 [TBL] [Abstract][Full Text] [Related]
12. Nuclear factor κB mediates suppression of canonical transient receptor potential 6 expression by reactive oxygen species and protein kinase C in kidney cells. Wang Y; Ding M; Chaudhari S; Ding Y; Yuan J; Stankowska D; He S; Krishnamoorthy R; Cunningham JT; Ma R J Biol Chem; 2013 May; 288(18):12852-65. PubMed ID: 23525112 [TBL] [Abstract][Full Text] [Related]
13. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Liu Y; Smith PW; Jones DR Mol Cell Biol; 2006 Dec; 26(23):8683-96. PubMed ID: 17000776 [TBL] [Abstract][Full Text] [Related]
14. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB. Ziesché E; Kettner-Buhrow D; Weber A; Wittwer T; Jurida L; Soelch J; Müller H; Newel D; Kronich P; Schneider H; Dittrich-Breiholz O; Bhaskara S; Hiebert SW; Hottiger MO; Li H; Burstein E; Schmitz ML; Kracht M Nucleic Acids Res; 2013 Jan; 41(1):90-109. PubMed ID: 23087373 [TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha. Horion J; Gloire G; El Mjiyad N; Quivy V; Vermeulen L; Vanden Berghe W; Haegeman G; Van Lint C; Piette J; Habraken Y J Biol Chem; 2007 May; 282(21):15383-93. PubMed ID: 17409387 [TBL] [Abstract][Full Text] [Related]
16. Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation. Dai Y; Rahmani M; Dent P; Grant S Mol Cell Biol; 2005 Jul; 25(13):5429-44. PubMed ID: 15964800 [TBL] [Abstract][Full Text] [Related]